Document ID: chunk:federal_register_of_legislation:F2025C00183:schedule:1:p3
Version: federal_register_of_legislation:F2025C00183
Segment Type: schedule
Provision Reference: sch 1 (pt 3/8)
Character Range: 11878–14533

not more than 5 occasions in 24 hours; and
 (ii) for a service described in item 65110—on one of not more than 2 occasions in 24 hours; and
 (b) the service was requested on a separate occasion to any other occasions on which the service was requested in that period; and
 (c) the pathology provider of the service writes on the account for the service that the service has a "rule 3 exemption".

1.2.5  Services to which clause 1.2.2 does not apply—chemical
  Clause 1.2.2 does not apply to a pathology service described in item 66500, 66503, 66506, 66509, 66512, 66584 or 66800 if:
 (a) the service is rendered in relation to one or more specimens taken on any of not more than 6 occasions in 24 hours; and
 (b) the service is rendered to an inpatient of a hospital; and
 (c) the service is rendered in relation to each specimen as soon as possible after the specimen is taken; and
 (d) the pathology provider of the service writes on the account for the service that the service has a "rule 3 exemption".

1.2.6  Referral of designated tests by one pathology practitioner to another
 (1) Designated test means a pathology test relating to a patient episode that is a test of a kind mentioned in item 65150, 65175, 66650, 66695, 66711, 66722, 66785, 66800, 66812, 66819, 66825, 69384, 69494, 71089, 71153 or 77165.
 (2) This clause applies if one or more designated tests are referred by a referring APP to a receiving APP in another approved pathology authority.
 (3) If a referring APP has rendered one or more designated tests:
 (a) item 65150, 65153, 65175, 65176, 65177, 65178, 66650, 66695, 66698, 66701, 66704, 66707, 66711, 66722, 66725, 66728, 66731, 66785, 66800, 66803, 66812, 66819, 66825, 69384, 69387, 69390, 69393, 69396, 69494, 69495, 71089, 71091, 71153, 71155, 71157, 77165, 71166 or 71167 (as the case may be) applies to each designated test rendered by the referring APP; and
 (b) subject to subclause (5), item 65158, 65181, 66652, 66697, 66715, 66724, 66790, 66805, 66817, 66821, 66827, 69401, 69498, 71092, 71156 or 71170 (as the case may be) applies to each designated test rendered by the receiving APP.
 (4) If a referring APP has not rendered a designated test:
 (a) for the first designated test that is rendered by the receiving APP—item 65157, 65180, 66651, 66696, 66714, 66723, 66789, 66804, 66816, 66820, 66826, 69400, 69497, 71090, 71154 or 71169 (as the case may be) applies; and
 (b) for each subsequent designated test (if any) that is rendered by the receiving APP—subject to subclause (6), item 65158, 65181, 66652, 66697, 66715, 66724, 66790, 66805, 66817, 66821, 66827, 69401, 69498, 71092, 71156 or 71170 (as the